Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predictors of Psychedelic Experience: A Thematic Analysis
Annie M. McCartney, H. T. McGovern, Alexander De Foe
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 4, pp. 411-419
Open Access | Times Cited: 19

Showing 19 citing articles:

Essentials of Informed Consent to Psychedelic Medicine
Mason Marks, Rebecca Weintraub Brendel, Carmel Shachar, et al.
JAMA Psychiatry (2024) Vol. 81, Iss. 6, pp. 611-611
Closed Access | Times Cited: 17
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 965-973
Open Access | Times Cited: 45
An Integrated theory of false insights and beliefs under psychedelics
H. T. McGovern, Hilary Jane Grimmer, Manoj K. Doss, et al.
Communications Psychology (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 10
Harnessing placebo: Lessons from psychedelic science
Chloé Pronovost-Morgan, Ido Hartogsohn, Johannes G. Ramaekers
Journal of Psychopharmacology (2023) Vol. 37, Iss. 9, pp. 866-875
Open Access | Times Cited: 15
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis
Kwonmok Ko, Ben Carter, Anthony J. Cleare, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 2105-2113
Open Access | Times Cited: 13
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
David B. Yaden, Marianna Graziosi, Anna Owen, et al.
Psychedelic Medicine (2025)
Closed Access
Preparations for rave music parties and consequences for attendees who consume psychedelic drugs
Yula Milshteyn, Moshe Bensimon
Journal of Substance Use and Addiction Treatment (2025), pp. 209637-209637
Closed Access
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis
Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, et al.
Pharmacopsychiatry (2025)
Closed Access
Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience
Madelene Palmer, Olivia Maynard
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 18
More than just joy: A qualitative analysis of participant experiences during nitrous oxide sedation
Petra Valtonen, Saara Markkanen, Kaija Järventausta, et al.
Acta Anaesthesiologica Scandinavica (2024) Vol. 68, Iss. 7, pp. 906-912
Open Access | Times Cited: 3
Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants
Patrick Vizeli, Erich Studerus, Friederike Holze, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
An Integrated theory of false insights and beliefs under psychedelics
Hugh McGovern, Hilary Jane Grimmer, Manoj K. Doss, et al.
(2023)
Open Access | Times Cited: 8
Personality traits explain the relationship between psychedelic use and less depression in a comparative study
David K. Sjöström, Emma Claesdotter‐Knutsson, Petri Kajonius
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence
Cianna J. Piercey, Bethany Gray, Angelina Sung, et al.
Psychedelic Medicine (2024) Vol. 2, Iss. 4, pp. 234-242
Closed Access | Times Cited: 1
Exploring the subjective experience of rave party participants in Israel who consume psychedelic drugs: a qualitative inquiry
Yula Milshteyn, Moshe Bensimon
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Are You Tripping Comfortably? Investigating the Relationship Between Harm Reduction and the Psychedelic experience
Maddie Palmer, Olivia Maynard
Research Square (Research Square) (2022)
Open Access | Times Cited: 4
Deconstructing Psychedelic Phenomenology: A thematic analysis of discrete phases of the psychedelic experience.
Hugh McGovern, Lura Bajo, Gerard Hassed, et al.
(2024)
Open Access
Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study
Maximillian J. Wood, Rosalind McAlpine, Sunjeev K. Kamboj
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Personality explains the relationship between psychedelic use and depression; a comparison study with non psychedelic users
David K. Sjöström, Emma Claesdotter‐Knutsson, Petri Kajonius
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top